Literature DB >> 21803130

Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.

Nidhi Gupta1, B K Binukumar, Surjit Singh, Aditya Sunkaria, Ramesh Kandimalla, Anil Bhansali, Kiran Dip Gill.   

Abstract

OBJECTIVE: Paraoxonase-1 (PON1), an HDL-C associated enzyme, protects lipoproteins from oxidation. There is evidence that PON1 enzyme activity is reduced in the patients with type 2 diabetes mellitus (T2DM). North-West Indian Punjabis, a distinct ethnic group has high incidence of T2DM. However till date there is no information regarding PON1 enzyme activities and PON1 polymorphisms in T2DM patients of this ethnic group.
METHODS: We identified polymorphisms in the coding Q192R, L55M and promoter -909G/C, -162A/G, -108C/T of the PON1 gene by using PCR-RFLP, multiplex PCR and allele specific oligonucleotide PCR assays in 250 T2DM patients and 300 healthy controls. We also assessed paraoxonase (PONase) and arylesterase (AREase) activities of PON1 enzyme.
RESULTS: The serum PONase (114.2 vs. 178.0nmol/min/ml) and AREase (62.7 vs. 82.5μmol/min/ml) activities were significantly lower (p<0.0001) in patients as compared to controls. PONase activity was affected by all the studied PON1 polymorphisms. However, AREase activity was not affected by any of these polymorphisms. Coding Q192R and promoter -909G/C polymorphisms showed significant differences in genotypic distribution. QR, RR (Q192R) and GC, CC (-909G/C) genotypes and L-C-A-R-G, L-T-A-R-G, L-T-G-Q-C haplotypes showed significant association with type 2 diabetes. No significant linkage disequilibrium was observed among the five polymorphisms.
CONCLUSION: Both PONase and AREase activities are lower in patients and this could lead to increased lipid peroxidation and accelerated atherosclerosis in them. PONase activity, but not AREase activity is influenced by PON1 polymorphisms. QR, RR, GC, CC genotypes and L-C-A-R-G, L-T-A-R-G, L-T-G-Q-C haplotypes are commoner in diabetics as compared to controls and may be related to genetic susceptibility to type 2 diabetes.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21803130     DOI: 10.1016/j.gene.2011.07.011

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  13 in total

1.  Significant interethnic differencies in functional variants of PON1 and P2RY12 genes in Roma and Hungarian population samples.

Authors:  Ingrid Janicsek; Csilla Sipeky; Judit Bene; Balazs Duga; Bela I Melegh; Bela Melegh; Katalin Sümegi; Luca Jaromi; Lili Magyari; Bela Melegh
Journal:  Mol Biol Rep       Date:  2014-10-09       Impact factor: 2.316

2.  Evaluation of Relationship Between Arylesterase-Based Activity and Genetic Variants of Paraoxonase1 in T2DM Patients within Golestan Province.

Authors:  Safoura Khajeniazi; Raheleh Shakeri; Abdoljalal Marjani
Journal:  Indian J Clin Biochem       Date:  2019-03-05

3.  PON-1 haplotype (-108C>T, L55M, and Q192R) modulates the serum levels and activity PONase promoting an atherogenic lipid profile in rheumatoid arthritis patients.

Authors:  Oscar Zaragoza-García; Iris Paola Guzmán-Guzmán; Ma Elena Moreno-Godínez; José Eduardo Navarro-Zarza; Verónica Antonio-Vejar; Mónica Ramírez; Isela Parra-Rojas
Journal:  Clin Rheumatol       Date:  2020-06-18       Impact factor: 2.980

Review 4.  The Relevance of Noncoding DNA Variations of Paraoxonase Gene Cluster in Atherosclerosis-Related Diseases.

Authors:  Anna Wysocka; Agnieszka Zwolak
Journal:  Int J Mol Sci       Date:  2021-02-21       Impact factor: 5.923

5.  European versus Asian differences for the associations between paraoxonase-1 genetic polymorphisms and susceptibility to type 2 diabetes mellitus.

Authors:  Jian-Quan Luo; Huan Ren; Mou-Ze Liu; Ping-Fei Fang; Da-Xiong Xiang
Journal:  J Cell Mol Med       Date:  2018-01-04       Impact factor: 5.310

6.  The association between paraoxonase 1 activity and the susceptibilities of diabetes mellitus, diabetic macroangiopathy and diabetic microangiopathy.

Authors:  Diling Wu; Chenfang Wu; Yanjun Zhong
Journal:  J Cell Mol Med       Date:  2018-07-07       Impact factor: 5.310

7.  Punicalagin Decreases Serum Glucose Levels and Increases PON1 Activity and HDL Anti-Inflammatory Values in Balb/c Mice Fed a High-Fat Diet.

Authors:  Dana Atrahimovich; Abraham O Samson; Ali Khattib; Jacob Vaya; Soliman Khatib
Journal:  Oxid Med Cell Longev       Date:  2018-07-31       Impact factor: 6.543

Review 8.  Paraoxonase (PON)-1: a brief overview on genetics, structure, polymorphisms and clinical relevance.

Authors:  Nelusha Shunmoogam; Poobalan Naidoo; Robert Chilton
Journal:  Vasc Health Risk Manag       Date:  2018-06-18

9.  Antioxidant and anti-inflammatory role of paraoxonase 1: implication in arteriosclerosis diseases.

Authors:  Dmitry Litvinov; Halleh Mahini; Mahdi Garelnabi
Journal:  N Am J Med Sci       Date:  2012-11

10.  Paraoxonase 1 activities and its gene promoter single nucleotide polymorphisms (-108, -126, and -162) in diabetes mellitus.

Authors:  Asefesadat Emami; Mohamadhasan Tajadini; Mehrdad Zeinalian; Mahtab Keshvari; Sedigheh Asgary
Journal:  Interv Med Appl Sci       Date:  2018-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.